DANESI, ROMANO
DANESI, ROMANO
Dipartimento di Oncologia ed Emato-Oncologia
TGF-β mRNA levels in circulating extracellular vesicles are associated with response to anti-PD1 treatment in metastatic melanoma
2024 S. Crucitta, F. Cucchiara, R. Marconcini, A. Bulleri, S. Manacorda, A. Capuano, D. Cioni, A. Nuzzo, E. de Jonge, R.H.J. Mathjissen, E. Neri, R.H.N. van Schaik, S. Fogli, R. Danesi, M. Del Re
Epigenetic patterns, accelerated biological aging, and enhanced epigenetic drift detected 6 months following COVID-19 infection: insights from a genome-wide DNA methylation study
2024 L. Calzari, D.F. Dragani, L. Zanotti, E. Inglese, R. Danesi, R. Cavagnola, A. Brusati, F. Ranucci, A.M. Di Blasio, L. Persani, I. Campi, S. De Martino, A. Farsetti, V. Barbi, M. Gottardi Zamperla, G.N. Baldrighi, C. Gaetano, G. Parati, D. Gentilini
Late onset toxicities associated with the use of CDK 4/6 inhibitors in hormone receptor positive (HR+), human epidermal growth factor receptor-2 negative (HER2-) metastatic breast cancer patients: a multidisciplinary, pan-EU position paper regarding their optimal management. The GIOCONDA project
2023 M.E. Cazzaniga, A. Ciaccio, R. Danesi, F.P. Duhoux, C. Girmenia, K. Zaman, H. Lindman, F. Luppi, D. Mavroudis, I. Paris, A. Olubukola, A. Samreen, C. Schem, C. Singer, A. Snegovoy
Do peripheral neuropathies differ among immune checkpoint inhibitors? Reports from the European post-marketing surveillance database in the past 10 years
2023 R. Ruggiero, N. Balzano, R. Di Napoli, F. Fraenza, C. Pentella, C. Riccardi, M. Donniacuo, M. Tesorone, R. Danesi, M. Del Re, F. Rossi, A. Capuano
Neurological Manifestations Related to Immune Checkpoint Inhibitors: Reverse Translational Research by Using the European Real-World Safety Data
2022 R. Ruggiero, B. Stelitano, F. Fraenza, G. di Mauro, C. Scavone, L. Sportiello, C. Rafaniello, R. Di Napoli, R. Danesi, M. Del Re, F. Rossi, A. Capuano
Optimizing the use of lenvatinib in combination with pembrolizumab in patients with advanced endometrial carcinoma
2022 D. Lorusso, R. Danesi, L.D. Locati, G. Masi, U. De Giorgi, A. Gadducci, S. Pignata, S. Roberto, A. Savarese, G. Valabrega, C. Zamagni, N. Colombo
Concomitant administration of proton pump inhibitors does not significantly affect clinical outcomes in metastatic breast cancer patients treated with ribociclib
2022 M. Del Re, S. Crucitta, C. Omarini, I. Bargagna, M. Mongillo, M. Palleschi, S. Stucci, I. Meattini, R. D'Onofrio, G. Lorenzini, P. Biondani, U. De Giorgi, C. Porta, L. Livi, S. Natalizio, A. Fontana, E. Giontella, L. Angelini, S. Fogli, R. Danesi
The amount of DNA combined with TP53 mutations in liquid biopsy is associated with clinical outcome of renal cancer patients treated with immunotherapy and VEGFR-TKIs
2022 M. Del Re, S. Crucitta, F. Paolieri, F. Cucchiara, E. Verzoni, F. Bloise, R. Ciampi, C. Mercinelli, A. Capuano, L. Sportiello, A. Martinetti, G. Procopio, L. Galli, C. Porta, S. Bracarda, R. Danesi
The challenge of the Molecular Tumor Board empowerment in clinical oncology practice: A Position Paper on behalf of the AIOM- SIAPEC/IAP-SIBioC-SIC-SIF-SIGU-SIRM Italian Scientific Societies
2022 A. Russo, L. Incorvaia, E. Capoluongo, P. Tagliaferri, A. Galvano, M. Del Re, U. Malapelle, R. Chiari, P. Conte, R. Danesi, M. Fassan, R. Ferrara, M. Genuardi, P. Ghiorzo, S. Gori, F. Guadagni, A. Marchetti, P. Marchetti, M. Midiri, N. Normanno, F. Passiglia, C. Pinto, N. Silvestris, G. Tallini, S. Vatrano, B. Vincenzi, S. Cinieri, G. Beretta
Corticosteroids in oncology: Use, overuse, indications, contraindications. An Italian Association of Medical Oncology (AIOM)/ Italian Association of Medical Diabetologists (AMD)/ Italian Society of Endocrinology (SIE)/ Italian Society of Pharmacology (SIF) multidisciplinary consensus position paper
2022 A. Faggiano, R. Mazzilli, A. Natalicchio, V. Adinolfi, A. Argentiero, R. Danesi, S. D'Oronzo, S. Fogli, M. Gallo, D. Giuffrida, S. Gori, M. Montagnani, A. Ragni, V. Renzelli, A. Russo, N. Silvestris, T. Franchina, E. Tuveri, S. Cinieri, A. Colao, F. Giorgino, M.C. Zatelli
Gene network Analysis Defines a Subgroup of Small Cell Lung Cancer patients With Short Survival
2022 F. Cucchiara, I. Petrini, A. Passaro, I. Attili, S. Crucitta, E. Pardini, F. de Marinis, R. Danesi, M. Del Re
Treatment-driven tumour heterogeneity and drug resistance: Lessons from solid tumours
2022 S. Crucitta, F. Cucchiara, R. Mathijssen, J. Mateo, A. Jager, A. Joosse, A. Passaro, I. Attili, I. Petrini, R. van Schaik, R. Danesi, M. Del Re
Drug-induced interstitial lung disease during cancer therapies: expert opinion on diagnosis and treatment
2022 P. Conte, P.A. Ascierto, G. Patelli, R. Danesi, A. Vanzulli, F. Sandomenico, P. Tarsia, A. Cattelan, A. Comes, M. De Laurentiis, A. Falcone, D. Regge, L. Richeldi, S. Siena
Early and unrestricted access to high-efficacy disease-modifying therapies: a consensus to optimize benefits for people living with multiple sclerosis
2022 M. Filippi, R. Danesi, T. Derfuss, M. Duddy, P. Gallo, R. Gold, E.K. Havrdova, B. Kornek, F. Sacca, M. Tintore, J. Weber, M. Trojano
The molecular profiling of solid tumors by liquid biopsy: a position paper of the AIOM-SIAPEC-IAP-SIBioC-SIC-SIF Italian Scientific Societies
2021 A. Russo, L. Incorvaia, M. Del Re, U. Malapelle, E. Capoluongo, V. Gristina, M. Castiglia, R. Danesi, M. Fassan, G. Giuffrè, S. Gori, A. Marchetti, N. Normanno, C. Pinto, G. Rossi, D. Santini, A. Sartore Bianchi, N. Silvestris, P. Tagliaferri, G. Troncone, S. Cinieri, G.D. Beretta
KDIGO Controversies Conference on onco-nephrology: understanding kidney impairment and solid-organ malignancies, and managing kidney cancer
2020 C. Porta, A. Bamias, F.R. Danesh, A. Debska-Slizien, M. Gallieni, M.A. Gertz, J.T. Kielstein, P. Tesarova, G. Wong, M. Cheung, D.C. Wheeler, W.C. Winkelmayer, J. Malyszko, A.K. Abu-Alfa, H. Amer, G. Beutel, J. Chapman, X. Chen, J. Chudek, L. Cosmai, R. Danesi, F. De Stefano, K. Iseki, E.A. Jaimes, K.D. Jhaveri, A. Jurczyszyn, R. Kazancioglu, A. Kitchlu, C. Kollmannsberger, A. Lahoti, Y. Li, M. Macia, T. Matsubara, D. Mitropoulos, E. Noiri, M.A. Perazella, P. Ronco, M.H. Rosner, M.J. Soler Romeo, B. Sprangers, W.M. Stadler, P.E. Stevens, T. Ladimir, V. Torres da Costa e Silva, D.H. Vesole, A. Vijayan, O. Viklicky, B.T. Workeneh, M. Yanagita, E. Zakharova
Understanding EGFR heterogeneity in lung cancer
2020 A. Passaro, U. Malapelle, M. Del Re, I. Attili, A. Russo, E. Guerini-Rocco, C. Fumagalli, P. Pisapia, F. Pepe, C. De Luca, F. Cucchiara, G. Troncone, R. Danesi, L. Spaggiari, F. De Marinis, C. Rolfo
Raccomandazioni per l’esecuzione di indagini molecolari su biopsia liquida in oncologia
2019 E. Capoluongo, M. Barberis, L. Crino, R. Danesi, M.D. Re, S. Gori, A. Marchetti, C. Marchio, N. Normanno, C. Pinto, A. Russo, A. Sapino, A.S. Bianchi, M. Truini, T. Venesio
Drug-drug interactions in breast cancer patients treated with CDK4/6 inhibitors
2019 S. Fogli, M. Del Re, G. Curigliano, R.H. van Schaik, P. Lancellotti, R. Danesi
Rechallenge for Patients with RAS and BRAF Wild-Type Metastatic Colorectal Cancer with Acquired Resistance to First-line Cetuximab and Irinotecan: A Phase 2 Single-Arm Clinical Trial
2019 C. Cremolini, D. Rossini, E. Dell'Aquila, S. Lonardi, E. Conca, M. Del Re, A. Busico, F. Pietrantonio, R. Danesi, G. Aprile, E. Tamburini, C. Barone, G. Masi, F. Pantano, F. Pucci, D.C. Corsi, N. Pella, F. Bergamo, E. Rofi, C. Barbara, A. Falcone, D. Santini